(Q72823659)
Statements
A phase III trial of high-dose cytosine arabinoside with or without etoposide in relapsed and refractory acute myelogenous leukemia. A Southeastern Cancer Study Group trial (English)
Vogler WR
McCarley DL
Stagg M
Bartolucci AA
Moore J
Martelo O
1 November 1994